Serum levels of FHR1 did not significantly differ between AMD patients and age-matched controls but differed from those of young healthy donors [74] indicating that circulating FHR1 levels increase not only with disease, but also with age. This evidence concerns the gene CFHR1 and age-related macular degeneration.